The MAP Group, a pan-European specialist pharmaceutical and biotechnology strategic consultancy focused on driving therapies through the complex medical, regulatory and market access landscape to ...

Ditch generic buyer personas! Discover a powerful framework for understanding what moves the needle for your audience and ...

At the time, MDMA, also known as the party drug ecstasy, had been outlawed in Australia since 1987, despite research ...

patient journey mapping, product and pricing strategy, and market segmentation. Lieberman will continue to be led by its existing management team. “Partnering with LCP represents a ...

A patient journey map is a useful tool to understand patient ... During each of these phases, the patients may experience a variety of emotions that can vary from person to person, but which ...

Davide Longo, an analyst from TP ICAP MIDCAP, maintained the Buy rating on Maps S.p.A. (MAPS – Research Report). The associated price target is ...

To truly serve your clients, you need to go beyond surface-level understanding and delve deep into the world of their ...

Rhapsody’s Chief Product Officer Jitin Asnaani discusses how to connect the dots between disparate patient records from multiple specialist departments to create a clear picture of patient needs.

In a world increasingly marked by political polarization and escalating environmental challenges, sustainability advocacy has ...

While psychedelics can lead to powerful experiences and new insights, they don’t directly "fix" us or create lasting change ...